Cano Health, Inc. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of operations

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenue:
Capitated revenue (Related parties comprised $307,684, $235,509 and $0 for the years ended December 31, 2021, 2020 and 2019, respectively)
Fee-for-service and other revenue (Related parties comprised $645, $832 and $558 for the years ended December 31, 2021, 2020 and 2019, respectively)
Capitated revenue
Fee-for-service and other revenue
Total revenue
Operating expenses:
Third-party medical costs
Direct patient expense (Related parties comprised $10,592, $9,683 and $4,882 in the years ended December 31, 2023, 2022 and 2021, respectively)
Related Party
Total direct patient expense (Related parties comprised $10,592, $9,683 and $4,882 in the years ended December 31, 2023, 2022 and 2021, respectively)
Selling, general, and administrative expenses (Related parties comprised $6,417, $9,230 and $12,366 in the years ended December 31, 2023, 2022 and 2021, respectively)
Related Party
Total selling, general, and administrative expenses (Related parties comprised $6,417, $9,230 and $12,366 in the years ended December 31, 2023, 2022 and 2021, respectively)
Depreciation and amortization expense (excluding accelerated amounts)
Accelerated depreciation and amortization for property and equipment, and right-of-use assets
Transaction costs
Change in fair value of contingent consideration
Goodwill impairment loss
Credit loss on other assets
Total operating expenses
Income (loss) from operations
Other income (expense):
Interest expense
Interest income
Class A common stock
Total interest income

Loss on extinguishment of debt
Change in fair value of embedded derivative
Change in fair value of warrant liabilities
Other income (expense)
Total other income (expense)
Net income (loss) before income tax expense
Income tax expense (benefit)
Net income (loss)
Class A common stock
Class B common stock
Total net income (loss)

Net income (loss) attributable to non-controlling interests
Net income (loss) attributable to Class A common stockholders
Weighted average shares outstanding
Class A Redeemable Ordinary Shares
Class B Non-redeemable Ordinary Shares
Basic and diluted net income (loss) per share
Class A common stock
Class B common stock
Net income (loss) per share attributable to Class A common stockholders, basic (in dollars per share)
Net income (loss) per share attributable to Class A common stockholders, diluted (in dollars per share)
Weighted-average shares outstanding
Basic (in shares)
Diluted (in shares)

Comments